IRCT20210101049905N1
Recruiting
Phase 2
Evaluating the effect of calcitriol on serum level of inflammatory biomarkers in patients with ischemic stroke
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hamedan University of Medical Sciences
- Enrollment
- 78
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 to 85 years
- •Focal neurological disorder
- •Clinical diagnosis of acute ischemic stroke
- •Radiological findings of MRI and CT are consistent with the clinical diagnosis of acute hemisphere stroke
- •No other concomitant inflammatory disease
- •Do not take drugs other than standard ischemic stroke treatments that alter the levels of the factors under consideration.
- •No pregnancy and lactation
- •Patients who have been hospitalized for the first 24 hours after a stroke.
- •Patients suffering from ischemic stroke for the first time
- •Do not use any combination with antioxidant effects in the past month
Exclusion Criteria
- •Evidence based on acute or chronic intracerebral hemorrhage and cerebral aneurysm
- •Existence of any etiology other than ischemia
- •Existence of any cognitive or behavioral disorders that lead to the patient not cooperating.
- •The patient's unwillingness to continue cooperating or taking the drug correctly
- •Drug intolerance and side effects
- •Consumption of any combination or drug with antioxidant effects except prescription drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Calcitriol supplementation in Nonalcoholic Fatty Liver Diseaseon-Alcoholic Fatty Liver disease (NAFLD).Fatty (change of) liver, not elsewhere classifiedIRCT2017053034222N1Ahvaz Jundishapur University of Medical Sciences160
Completed
Phase 3
Effect of Calciterol and Cinacalcate on hyperparathyroidismIRCT20190702044076N1Shahre-kord University of Medical Sciences60
Completed
Phase 2
Evaluation of the effect of calcitriol supplementation on diabetes control and its complications in hyperlipidemic patients with type 2 diabetes mellitus, Shiraz, 2009IRCT138806282480N1Shiraz university of medical sciences70
Completed
Phase 2
Effects of calcitriol on the complications of hematopoietic stem cell transplantatioCondition 1: Hodgkin lymphoma. Condition 2: Non-Hodgkin lymphoma. Condition 3: Multiple myeloma.Hodgkin lymphomaFollicular lymphoma, Non-follicular lymphoma, Mature T/NK-cell lymphomas, Other and unspecified types of non-Hodgkin lymphomaMultiple myeloma and malignant plasma cell neoplasmsC82, C83,IRCT2016052727435N2Research Center of the Hematology and Oncology and Stem Cell Transplantation, Shariati Hospital80
Recruiting
Phase 2
Assessment of the effect of topical calcitriol on Chronic Rhinosinusitischronic rhinosinusitis with and without polyps.chronic sinusitisIRCT201705173186N11Vice chancellor for research, Hamadan University of Medical Sciences60